Tag: Bryn Pharma

Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...

Company is developing UTULY for intranasal emergency epinephrine delivery.
Bryn Pharma Intranasal Epinephrine Device

Bryn Shows UTULY™ Intranasal Epinephrine Absorbs Faster and is Sustained Longer...

A needleless, self administered nasal spray intended to be used in anaphylactic emergencies in place of traditional auto-injectors.
Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis

Nasal administration of epinephrine takes another step forward.
Needless Epinephrine Alternatives

They’re Coming: Needle-Free Emergency Epinephrine Options Currently in Trials

For some, the needle is a barrier to administration but alternatives are on the horizon.
Neffy Intranasal Epinephrine Device

CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...

The market for epinephrine delivery may expand to include non-needle alternatives next year.
Intranasal Spray

Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting

Emergency epinephrine without the jab makes strides.
Intranasal Delivery

Intranasal Delivery of Emergency Epinephrine Takes Another Step Toward Realization

Another company is reporting promising results in the race to bring an intranasal device to market.
Intranasal Spray

Single Dose of Intranasal Epinephrine Comparable to That Delivered via Auto-Injector

Study showed no safety issues and no serious or unexpected adverse events.
Bryn Pharma Intranasal Epinephrine Device

Intra-Nasal Epinephrine Takes Step Forward After Three Positive Pre-Clinical Studies

Intranasal delivery of epinephrine would eliminate the needle and by doing so remove a potential psychological barrier to prompt administration in an emergency.
Nose

Bryn Study Evaluates Effects of Nasal Congestion on Intranasal Administration of...

“A treatment method like intranasal delivery that is easier and more convenient may lead to increased compliance and result in a reduced time to treat an anaphylactic event.”